These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 7583566)

  • 1. A new case of apoA-I deficiency showing codon 8 nonsense mutation of the apoA-I gene without evidence of coronary heart disease.
    Takata K; Saku K; Ohta T; Takata M; Bai H; Jimi S; Liu R; Sato H; Kajiyama G; Arakawa K
    Arterioscler Thromb Vasc Biol; 1995 Nov; 15(11):1866-74. PubMed ID: 7583566
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ApoA-IHelsinki (Lys107-->0) associated with reduced HDL cholesterol and LpA-I:A-II deficiency.
    Tilly-Kiesi M; Zhang Q; Ehnholm S; Kahri J; Lahdenperä S; Ehnholm C; Taskinen MR
    Arterioscler Thromb Vasc Biol; 1995 Sep; 15(9):1294-306. PubMed ID: 7670941
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Apolipoprotein A-I deficiency due to a codon 84 nonsense mutation of the apolipoprotein A-I gene.
    Matsunaga T; Hiasa Y; Yanagi H; Maeda T; Hattori N; Yamakawa K; Yamanouchi Y; Tanaka I; Obara T; Hamaguchi H
    Proc Natl Acad Sci U S A; 1991 Apr; 88(7):2793-7. PubMed ID: 1901417
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Marked high density lipoprotein deficiency due to apolipoprotein A-I Tomioka (codon 138 deletion).
    Wada M; Iso T; Asztalos BF; Takama N; Nakajima T; Seta Y; Kaneko K; Taniguchi Y; Kobayashi H; Nakajima K; Schaefer EJ; Kurabayashi M
    Atherosclerosis; 2009 Nov; 207(1):157-61. PubMed ID: 19473658
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High density lipoprotein deficiency with xanthomas. A defect in reverse cholesterol transport caused by a point mutation in the apolipoprotein A-I gene.
    Lackner KJ; Dieplinger H; Nowicka G; Schmitz G
    J Clin Invest; 1993 Nov; 92(5):2262-73. PubMed ID: 7693760
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Apolipoprotein A-I Q[-2]X causing isolated apolipoprotein A-I deficiency in a family with analphalipoproteinemia.
    Ng DS; Leiter LA; Vezina C; Connelly PW; Hegele RA
    J Clin Invest; 1994 Jan; 93(1):223-9. PubMed ID: 8282791
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of apoA- and apoB-containing lipoprotein particles in a variant of familial apoA-I deficiency with planar xanthoma: the metabolic significance of LP-A-II particles.
    Bekaert ED; Alaupovic P; Knight-Gibson CS; Laux MJ; Pelachyk JM; Norum RA
    J Lipid Res; 1991 Oct; 32(10):1587-99. PubMed ID: 1797940
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel two nucleotide deletion in the apolipoprotein A-I gene, apoA-I Shinbashi, associated with high density lipoprotein deficiency, corneal opacities, planar xanthomas, and premature coronary artery disease.
    Ikewaki K; Matsunaga A; Han H; Watanabe H; Endo A; Tohyama J; Kuno M; Mogi J; Sugimoto K; Tada N; Sasaki J; Mochizuki S
    Atherosclerosis; 2004 Jan; 172(1):39-45. PubMed ID: 14709355
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel homozygous missense mutation in the apo A-I gene with apo A-I deficiency.
    Huang W; Sasaki J; Matsunaga A; Nanimatsu H; Moriyama K; Han H; Kugi M; Koga T; Yamaguchi K; Arakawa K
    Arterioscler Thromb Vasc Biol; 1998 Mar; 18(3):389-96. PubMed ID: 9514407
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Familial HDL deficiency due to marked hypercatabolism of normal apoA-I.
    Emmerich J; Vergès B; Tauveron I; Rader D; Santamarina-Fojo S; Shaefer J; Ayrault-Jarrier M; Thiéblot P; Brewer HB
    Arterioscler Thromb; 1993 Sep; 13(9):1299-306. PubMed ID: 8364014
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel nonsense apolipoprotein A-I mutation (apoA-I(E136X)) causes low HDL cholesterol in French Canadians.
    Dastani Z; Dangoisse C; Boucher B; Desbiens K; Krimbou L; Dufour R; Hegele RA; Pajukanta P; Engert JC; Genest J; Marcil M
    Atherosclerosis; 2006 Mar; 185(1):127-36. PubMed ID: 16023124
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of high density lipoprotein particles in familial apolipoprotein A-I deficiency.
    Santos RD; Schaefer EJ; Asztalos BF; Polisecki E; Wang J; Hegele RA; Martinez LR; Miname MH; Rochitte CE; Da Luz PL; Maranhão RC
    J Lipid Res; 2008 Feb; 49(2):349-57. PubMed ID: 17991756
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Apolipoprotein A-I deficiency with accumulated risk for CHD but no symptoms of CHD.
    Yokota H; Hashimoto Y; Okubo S; Yumoto M; Mashige F; Kawamura M; Kotani K; Usuki Y; Shimada S; Kitamura K; Nakahara K
    Atherosclerosis; 2002 Jun; 162(2):399-407. PubMed ID: 11996960
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Apolipoprotein A-I(Zavalla) (Leu159-->Pro): HDL cholesterol deficiency in a kindred associated with premature coronary artery disease.
    Miller M; Aiello D; Pritchard H; Friel G; Zeller K
    Arterioscler Thromb Vasc Biol; 1998 Aug; 18(8):1242-7. PubMed ID: 9714130
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A nonsense mutation in the apolipoprotein A-I gene is associated with high-density lipoprotein deficiency and periorbital xanthelasmas.
    Römling R; von Eckardstein A; Funke H; Motti C; Fragiacomo GC; Noseda G; Assmann G
    Arterioscler Thromb; 1994 Dec; 14(12):1915-22. PubMed ID: 7981179
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Severe type III hyperlipoproteinemia associated with unusual apolipoprotein E1 phenotype and epsilon 1/'null' genotype.
    Feussner G; Funke H; Weng W; Assmann G; Lackner KJ; Ziegler R
    Eur J Clin Invest; 1992 Sep; 22(9):599-608. PubMed ID: 1360898
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A cysteine-containing truncated apo A-I variant associated with HDL deficiency.
    Moriyama K; Sasaki J; Takada Y; Matsunaga A; Fukui J; Albers JJ; Arakawa K
    Arterioscler Thromb Vasc Biol; 1996 Dec; 16(12):1416-23. PubMed ID: 8977444
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Case report: A novel apolipoprotein A-I missense mutation apoA-I (Arg149Ser)Boston associated with decreased lecithin-cholesterol acyltransferase activation and cellular cholesterol efflux.
    Anthanont P; Asztalos BF; Polisecki E; Zachariah B; Schaefer EJ
    J Clin Lipidol; 2015; 9(3):390-5. PubMed ID: 26073399
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Familial lecithin:cholesterol acyltransferase deficiency: molecular analysis of a compound heterozygote: LCAT (Arg147 --> Trp) and LCAT (Tyr171 --> Stop).
    Guerin M; Dachet C; Goulinet S; Chevet D; Dolphin PJ; Chapman MJ; Rouis M
    Atherosclerosis; 1997 May; 131(1):85-95. PubMed ID: 9180249
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HDL deficiency due to a new insertion mutation (ApoA-INashua) and review of the literature.
    Lee EY; Klementowicz PT; Hegele RA; Asztalos BF; Schaefer EJ
    J Clin Lipidol; 2013; 7(2):169-73. PubMed ID: 23415437
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.